Bliss GVS Pharma Ltd
Anish Singh is a finance professional with extensive experience in various leadership roles. Currently serving as Deputy General Manager of Finance & Accounts at Bliss GVS Pharma Ltd. since February 2025, Anish previously held the position of Finance Business Partner - Lead for Foreign Subsidiaries at ACG World from May 2011 to February 2025. Anish's career also includes positions such as EA to Director of Finance at HSCL, Executive Finance at Pam Glatt, and EA to MD at NPL GROUP. Prior experience includes roles at ICICI Bank as Regional Risk & Training Manager and Commercial Trainee at Siemens. Anish started the professional journey as a CA Article Trainee at Nirmal Kaushik & Co. Anish holds a FCMA in Management Accounting, Costing, and Finance from the Institute of Cost Accountants of India, an Accounting Technician Certificate from the Institute of Chartered Accountants of India, and a Bachelor of Commerce degree from Calcutta University.
This person is not in any teams
This person is not in any offices
Bliss GVS Pharma Ltd
Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations. The Company offers a range of suppositories and pessaries catering to various therapeutic segments. The Company's suppositories products include Anti-Malarial, Anti-Haemorrhoidal, Anti-Spasmodic, Laxatives, Anti-Inflammatory, Anti-Emetic and Anti-Pyretic. The Company's pessaries products include Anti-Fungal, Anti-Bacterial, Contraceptive and Lubricants. The Company's Pharma products include Tablets, Capsules, Dry powder for injection, Injection, Syrups, Eye/Ear Drops, Nasal Solution, Soft Gelatin Capsules, Lotions, Sachets and Transdermal Patches. Its Other Healthcare products include Lozenges, Nasal Inhaler, Solution, Soap, Vaginal Wash, Powder, Shampoo, Spray, Balm, Roll On, Petroleum Jelly and Cream. Its suppositories are offered under various brands, such as ANOMEX, ANOMEX DS, COMIT 50, MEFINOL, MELANEZ, TYRIDOL, VIGOTAMIN, CONLAX 5/10, GMETH - 50/100 and GV-SOFT.